OpenLB
Open Library of Bioscience
Advanced Search
Endocrine
06, 2021;72 (3): 619-632.

Radiofrequency ablation and thyroid nodules: updated systematic review.

Haris Muhammad, Prasanna Santhanam, Jonathon O Russell
Author Information
  1. Haris Muhammad: Department of Internal Medicine, Greater Baltimore Medical Center, Towson, MD, 21204, USA.
  2. Prasanna Santhanam: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. Psantha1@jhmi.edu. ORCID
  3. Jonathon O Russell: Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
PMID: 33449296 DOI: 10.1007/s12020-020-02598-6

Abstract

PURPOSE: In the thyroid gland, radiofrequency ablation (RFA) is being applied to both benign nodules and cancers internationally, while interest is also growing in the West. Benign thyroid nodules (BTNs) may be candidates for intervention when symptoms develop. For differentiated thyroid cancers (DTC), surgery is currently the first-line treatment. However, for candidates with high surgical risk or those who refuse to undergo repeated surgery, newer techniques such as RFA are an option. Surgery is associated with complications including hypothyroidism, voice change, hypocalcemia, and a scar. RFA has been used in Asian and European institutions as an alternative to surgery, but is relatively new in North America. Although RFA is not associated with significant complications, few randomized control trials have assessed its efficacy. The studies to date suggest a low rate of severe complications and a small need for thyroid hormone replacement following RFA. Further large-scale studies focusing on a Western population are needed. The aim of this review is to evaluate the evidence with respect to the current studies and data about the safety and efficacy of radiofrequency ablation for the management of BTNs and DTC.
METHODS: We systematically searched the PubMed/MEDLINE, EMBASE, Clinical Queries, and Web of Science databases, for articles published up to April 30th, 2020.
RESULTS: Total of 75 studies that met the inclusion criteria were included in the review. Thirty-five studies focused on RFA use for solid nodules, 12 studies on predominantly cystic nodules, 10 for autonomously functioning thyroid nodules, and 18 studied were published on differentiated thyroid cancer.
CONCLUSIONS: RFA seems to be an effective and safe alternative to surgery in high-risk surgical patients with thyroid cancers and for selected BTNs. Additional trials with longer follow-up in North American patients are needed to validate its full role in the armamentarium of thyroid ologists.

Keywords

Levothyroxine Papillary thyroid cancer RFA Radiofrequency ablation Thyroid nodules

References

  1. H. Dobnig, K. Amrein, Monopolar radiofrequency ablation of thyroid nodules: a prospective austrian single-center study. Thyroid 28(4), 472–480 (2018) [PMID: 29490593]
  2. Y. Guang et al. Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up. BMC Cancer 19(1), 147 (2019) [PMID: 30760229]
  3. L. Hegedus, Thyroid ultrasonography as a screening tool for thyroid disease. Thyroid 14(11), 879–880 (2004) [PMID: 15671764]
  4. Y. Ito et al. Papillary microcarcinoma of the thyroid: how should it be treated?. World J. Surg. 28(11), 1115–1121 (2004) [PMID: 15490053]
  5. Y. Ito et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13(4), 381–387 (2003) [PMID: 12804106]
  6. S.Y. Su, S. Grodski, J.W. Serpell, Hypothyroidism following hemithyroidectomy: a retrospective review. Ann. Surg. 250(6), 991–994 (2009) [PMID: 19779329]
  7. S.S. Chen et al. Optimizing levothyroxine dose adjustment after thyroidectomy with a decision tree. J. Surg. Res. 244, 102–106 (2019) [PMID: 31279993]
  8. E.K. Alexander et al. Natural history of benign solid and cystic thyroid nodules. Ann. Intern. Med. 138(4), 315–318 (2003) [PMID: 12585829]
  9. A. Bergenfelz et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch. Surg. 393(5), 667–673 (2008) [PMID: 18633639]
  10. L. Hegedus, Therapy: a new nonsurgical therapy option for benign thyroid nodules?. Nat. Rev. Endocrinol. 5, 476–478 (2009). [PMID: 19690558]
  11. H. Rhim et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics 21(Spec No), S17–S35 (2001) [PMID: 11598245]
  12. L. Buscarini, S. Rossi, Technology for radiofrequency thermal ablation of liver tumors. Semin. Laparosc. Surg. 4(2), 96–101 (1997) [PMID: 10401146]
  13. A. Barile et al. Interventional radiology of the thyroid gland: critical review and state of the art. Gland Surg. 7(2), 132–146 (2018) [PMID: 29770309]
  14. J. Lee et al. Feasibility of adjustable electrodes for radiofrequency ablation of benign thyroid nodules. Korean J. Radiol. 21(3), 377–383 (2020) [PMID: 32090530]
  15. J.H. Kim et al. 2017 Thyroid radiofrequency ablation guideline: korean society of thyroid radiology. Korean J. Radiol. 19(4), 632–655 (2018) [PMID: 29962870]
  16. H. Gharib et al. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J. Clin. Endocrinol. Metab. 98(10), 3949–3957 (2013) [PMID: 23956350]
  17. E. Papini, C.M. Pacella, L. Hegedus, Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedures: from the shadows into an array of applications. Eur. J. Endocrinol. 170(4), R133–R146 (2014) [PMID: 24459238]
  18. Y. Che et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. Am. J. Neuroradiol. 36(7), 1321–1325 (2015) [PMID: 25814656]
  19. J.H. Baek et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. Am. J. Roentgenol. 194(4), 1137–1142 (2010)
  20. J.Y. Huh et al. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session-prospective randomized study. Radiology 263(3), 909–916 (2012) [PMID: 22438360]
  21. N. Arora et al. Do benign thyroid nodules have malignant potential? An evidence-based review. World J. Surg. 32(7), 1237–1246 (2008) [PMID: 18327528]
  22. C.C. Wang et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 21(3), 243–251 (2011) [PMID: 21190442]
  23. S.M. Ha et al. Does radiofrequency ablation induce neoplastic changes in benign thyroid nodules: a preliminary study. Endocrinol. Metab. (Seoul.) 34(2), 169–178 (2019)
  24. C. Dobrinja et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules. Int. J. Endocrinol. 2015, 576576 (2015) [PMID: 26265914]
  25. F. Garino et al. Long-lasting shrinkage of thyroid nodules after radiofrequency ablation. A 2 years prospective study. Thyroid 25, A172 (2015)
  26. R. Cervelli et al. Radiofrequency ablation in the treatment of benign thyroid nodules: an efficient and safe alternative to surgery. J. Vasc. Interv. Radiol. 28(10), 1400–1408 (2017) [PMID: 28844832]
  27. M. Deandrea et al. Long-lasting thyroid nodules shrinkage after radiofrequency ablation at 1 year follow-up on a prospective study. Eur. Thyroid J. 3, 135 (2014)
  28. M. Deandrea et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med. Biol. 34(5), 784–791 (2008) [PMID: 18207307]
  29. M. Deandrea et al. Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid 25(8), 890–896 (2015) [PMID: 26061686]
  30. S. Spiezia et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 19(3), 219–225 (2009) [PMID: 19265492]
  31. J. Aldea Martínez et al. Radiofrequency ablation of thyroid nodules: a long-term prospective study of 24 patients. J. Vasc. Interv. Radiol. 30(10), 1567–1573 (2019) [PMID: 31375448]
  32. H.S. Ahn et al. Radiofrequency ablation of benign thyroid nodules: evaluation of the treatment efficacy using ultrasonography. Ultrasonography 35(3), 244–252 (2016) [PMID: 27101983]
  33. O. Hamidi et al. Outcomes of radiofrequency ablation therapy for large benign thyroid nodules: a Mayo Clinic Case Series. Mayo Clin. Proc. 93(8), 1018–1025 (2018) [PMID: 29572016]
  34. A. Ben Hamou et al. Safety and efficacy of thermal ablation (radiofrequency and laser): should we treat all types of thyroid nodules?. Int. J. Hyperth. 36(1), 666–676 (2019)
  35. M. Sambo Salas et al. Efficacy of radiofrequency ablation (RFA) in clinical, morphological and functional control of large, solid, symptomatic and benign thyroid nodules: preliminary outcomes of a spanish multicenter study after the first month of follow-up. Thyroid 25, A173 (2015)
  36. H. Dobnig, K. Amrein, Monopolar radiofrequency ablation of thyroid nodules: a prospective austrian single-center study. Thyroid 28(4), 472–480 (2018) [PMID: 29490593]
  37. G. Mauri et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int. J. Hyperth. 33(3), 295–299 (2017)
  38. S.L. Jung et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J. Radiol. 19(1), 167–174 (2018) [PMID: 29354014]
  39. W.K. Jeong et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur. Radiol. 18(6), 1244–1250 (2008) [PMID: 18286289]
  40. M.U. Ugurlu et al. Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study. World J. Surg. 39(4), 961–968 (2015) [PMID: 25446486]
  41. W.W. Yue et al. Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study. Endocrine 55(2), 485–495 (2017) [PMID: 27905049]
  42. H.K. Lim et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur. Radiol. 23(4), 1044–1049 (2013) [PMID: 23096937]
  43. X.L. Li et al. Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. Br. J. Radiol. 89(1059), 20150858 (2016) [PMID: 26800232]
  44. R. Cesareo et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J. Clin. Endocrinol. Metab. 100(2), 460–466 (2015) [PMID: 25387256]
  45. S. Bernardi et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int. J. Endocrinol. 2014, 934595 (2014) [PMID: 25045352]
  46. R. Valcavi, P. Tsamatropoulos, Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: A 2-year follow-up study in 40 patients. Endocr. Pract. 21(8), 887–896 (2015) [PMID: 26121459]
  47. J.S. Sim et al. Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume. Int. J. Hyperth. 33(8), 905–910 (2017)
  48. K.D. Kohlhase et al. Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int. J. Hyperth. 32(5), 511–516 (2016)
  49. S. Jawad et al. Ultrasound-guided radiofrequency ablation (RFA) of benign symptomatic thyroid nodules - initial UK experience. Br. J. Radiol. 92(1098), 20190026 (2019) [PMID: 31084496]
  50. M. Deandrea et al. Long-term efficacy of a single session of RFA for benign thyroid nodules: a longitudinal 5-year observational study. J. Clin. Endocrinol. Metab. 104(9), 3751–3756 (2019) [PMID: 30860579]
  51. G. Turtulici et al. Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med. Biol. 40(7), 1447–1452 (2014) [PMID: 24785443]
  52. P. Rabuffi et al. Treatment of thyroid nodules with radiofrequency: a 1-year follow-up experience. J. Ultrasound 22(2), 193–199 (2019) [PMID: 30945239]
  53. F. Feroci et al. Radiofrequency thermal ablation of benign thyroid nodules: the correlation between ultrasound nodule characteristics and results. Surg. Innov. 27, 1553350620913134 (2020)
  54. R. Cesareo et al. Laser ablation versus radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomized, parallel, open-label, trial (LARA trial). Thyroid 30(6), 847–856 (2020) [PMID: 32056501]
  55. Y. Korkusuz et al. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods?. Eur. Radiol. 28(3), 929–935 (2018) [PMID: 28894936]
  56. C.K. Zhao et al. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: first results of CEUS evaluation. Clin. Hemorheol. Microcirc. 65(4), 393–405 (2017) [PMID: 27983547]
  57. M. Deandrea et al. Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study. Eur. J. Endocrinol. 180(1), 79–87 (2019) [PMID: 30407921]
  58. D. Cui et al. Efficacy and safety of a combination of hydrodissection and radiofrequency ablation therapy for benign thyroid nodules larger than 2 cm: a retrospective study. J. Cancer Res. Ther. 15(2), 386–393 (2019) [PMID: 30964116]
  59. J.H. Baek et al. Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules: a randomized clinical trial. Korean J. Radiol. 16(6), 1332–1340 (2015) [PMID: 26576124]
  60. J.Y. Sung et al. Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation?. Am. J. Roentgenol. 196(2), W210–W214 (2011)
  61. Y.S. Kim et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16(4), 361–367 (2006) [PMID: 16646682]
  62. E. Aysan et al. Single-session radiofrequency ablation on benign thyroid nodules: a prospective single center study radiofrequency ablation on thyroid. Langenbecks Arch. Surg. 401(3), 357–363 (2016) [PMID: 27013327]
  63. H. Dobnig et al. Radiofrequency ablation of solid and cystic thyroid nodules: experiences by an Austrian endocrinologist in private practice. Endocr. Rev. 38(3), (2020). https://endo.confex.com/endo/2017endo/meetingapp.cgi/Paper/29744
  64. M.J. Hong et al. Radiofrequency ablation is a thyroidfunction-preserving treatment for patients with bilateral benign thyroid nodules. Eur. Thyroid J. 3, 141 (2014)
  65. N.L. Vuong et al. Radiofrequency ablation for benign thyroid nodules: 1-year follow-up in 184 patients. World J. Surg. 43(10), 2447–2453 (2019) [PMID: 31165252]
  66. J.Y. Sung et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 269(1), 293–300 (2013) [PMID: 23616630]
  67. J.H. Lee et al. Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J. Surg. 34(7), 1488–1493 (2010) [PMID: 20376445]
  68. H.M. Yoon et al. Combination therapy consisting of ethanol and radiofrequency ablation for predominantly cystic thyroid nodules. Am. J. Neuroradiol. 35(3), 582–586 (2014) [PMID: 23969340]
  69. R. Cesareo et al. Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. Int. J. Hyperth. 34(5), 617–623 (2018)
  70. J.Y. Sung et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid 25(1), 112–117 (2015) [PMID: 25320840]
  71. R. Cervelli et al. Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: a retrospective study. Clin. Endocrinol. 90(4), 608–616 (2019)
  72. A. Faggiano et al. Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J. Clin. Endocrinol. Metab. 97(12), 4439–4445 (2012) [PMID: 23019349]
  73. J.H. Baek et al. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J. Surg. 33(9), 1971–1977 (2009) [PMID: 19575141]
  74. S. Bernardi et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine 57(3), 402–408 (2017) [PMID: 27848197]
  75. C. Cappelli et al. Radiofrequency ablation of functioning and non-functioning thyroid nodules: a single institution 12-month survey. J. Endocrinol. Investig. 43(4), 477–482 (2019)
  76. J.H. Baek et al. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am. J. Roentgenol. 197(2), W331–W336 (2011)
  77. S.J. Lee et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J. Radiol. 15(6), 817–826 (2014) [PMID: 25469095]
  78. F.D. Gilliland et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 79(3), 564–573 (1997) [PMID: 9028369]
  79. N.E. Gulcelik, M.A. Gulcelik, B. Kuru, Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch. Otolaryngol. Head. Neck Surg. 134(12), 1312–1315 (2008) [PMID: 19075128]
  80. S.M. Ha et al. Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes. Int. J. Hyperth. 33(8), 931–937 (2017)
  81. S.Y. Jeong et al. Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma. Int. J. Hyperth. 34(5), 611–616 (2018)
  82. B.R. Haugen et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016) [PMID: 26462967]
  83. M. Zhang et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid 30(3), 408–417 (2020) [PMID: 31910107]
  84. J.H. Kim et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int. J. Hyperth. 33(2), 212–219 (2017)
  85. H.Y. Kim et al. Primary papillary thyroid carcinoma previously treated incompletely with radiofrequency ablation. J. Cancer Res. Ther. 6(3), 310–312 (2010) [PMID: 21119260]
  86. B. Ma et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review. Thyroid 28(9), 1134–1142 (2018) [PMID: 29962285]
  87. H.K. Lim et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur. Radiol. 25(1), 163–170 (2015) [PMID: 25199815]
  88. S. Mazzeo et al. mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study. J. Endocrinol. Investig. 41(12), 1389–1399 (2018)
  89. J.H. Kim et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology 276(3), 909–918 (2015) [PMID: 25848897]
  90. Y. Choi, et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study. Int. J. Hyperth 36(1), 359–367 (2019)
  91. S.R. Chung et al. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer. Eur. Radiol. 29(9), 4897–4903 (2019) [PMID: 30805701]
  92. M. Ding et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin. Radiol. 74(9), 712–717 (2019) [PMID: 31253420]
  93. J.M. Monchik et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann. Surg. 244(2), 296–304 (2006) [PMID: 16858194]
  94. K.W. Park et al. Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann. Surg. Oncol. 18(9), 2564–2568 (2011) [PMID: 21347777]
  95. D.E. Dupuy et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130(6), 971–977 (2001) [PMID: 11742325]
  96. D. Xu et al. Radiofrequency ablation for postsurgical thyroid removal of differentiated thyroid carcinoma. Am. J. Transl. Res. 8(4), 1876–1885 (2016) [PMID: 27186311]
  97. H.K. Lim et al. US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population. Korean J. Radiol. 20(12), 1653–1661 (2019) [PMID: 31854153]
  98. J.P. Guenette, J.M. Monchik, D.E. Dupuy, Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J. Vasc. Inter. Radiol. 24(5), 672–679 (2013)
  99. J.H. Baek et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology 262(1), 335–342 (2012) [PMID: 21998044]
  100. E.J. Ha, J.H. Baek, J.H. Lee, Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J. Radiol. 16(4), 749–766 (2015) [PMID: 26175574]
  101. C. Kim et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur. Radiol. 27(8), 3128–3137 (2017) [PMID: 27975148]
  102. J.H. Baek et al. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am. J. Roentgenol. 197(2), W331–W336 (2011)
  103. S.J. Stoll et al. Thyroid hormone replacement after thyroid lobectomy. Surgery 146(4), 554–558 (2009). discussion 558–60 [PMID: 19789012]
  104. E.J. Ha et al. Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy. Thyroid 23(3), 289–293 (2013) [PMID: 23013110]
  105. R.C.I. Mateo, J.V. Hennessey, Thyroxine and treatment of hypothyroidism: seven decades of experience. Endocrine 66(1), 10–17 (2019) [PMID: 31321670]
  106. M.M. Finucane et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377(9765), 557–567 (2011) [PMID: 21295846]
  107. S. Rahman et al. Obesity is associated with BRAF V600E-mutated thyroid cancer. Thyroid 30(10), 1518–1527 (2020) [PMID: 32228152]
  108. C.C. Li, et al. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors. J. Endocrinol. Investig 43(9), 1283–1299 (2020)

MeSH Term

Catheter Ablation
Humans
Radiofrequency Ablation
Thyroid Neoplasms
Thyroid Nodule
Treatment Outcome
Journal Article Systematic Review
Article has an altmetric score of 3

Word Cloud

Created with Highcharts 10.0.0thyroidRFAnodulesstudiesablationsurgerycancersBTNscomplicationsreviewradiofrequencycandidatesdifferentiatedDTCsurgicalassociatedalternativeNorthtrialsefficacyneededpublishedcancerpatientsRadiofrequencyPURPOSE:glandappliedbenigninternationallyinterestalsogrowingWestBenignmayinterventionsymptomsdevelopcurrentlyfirst-linetreatmentHoweverhighriskrefuseundergorepeatednewertechniquesoptionSurgeryincludinghypothyroidismvoicechangehypocalcemiascarusedAsianEuropeaninstitutionsrelativelynewAmericaAlthoughsignificantrandomizedcontrolassesseddatesuggestlowrateseveresmallneedhormonereplacementfollowinglarge-scalefocusingWesternpopulationaimevaluateevidencerespectcurrentdatasafetymanagementMETHODS:systematicallysearchedPubMed/MEDLINEEMBASEClinicalQueriesWebSciencedatabasesarticlesApril30th2020RESULTS:Total75metinclusioncriteriaincludedThirty-fivefocusedusesolid12predominantlycystic10autonomouslyfunctioning18studiedCONCLUSIONS:seemseffectivesafehigh-riskselectedAdditionallongerfollow-upAmericanvalidatefullrolearmamentariumologistsnodules:updatedsystematicLevothyroxinePapillaryThyroid

Similar Articles

Cited By